A cancer patient advocate worries that President Donald Trump's hiring freeze could put a crimp in FDA's newly launched Oncology Center of Excellence (OCE), an initiative aimed at speeding patient access to cancer treatments and which is viewed as a possible model for creation of other disease-focused centers in the future. FDA formally launched OCE Thursday (Jan. 19) as part of the Cancer Moonshot Initiative. While the new center is expected to streamline approvals of cancer products, it will require...